MSB 3.42% $1.21 mesoblast limited

Cell Therapy News/Articles, page-5257

  1. 2,146 Posts.
    lightbulb Created with Sketch. 508
    Is it correct in assuming that 3 days after the 300th patient is dosed then there is zero chance of it being stopped for efficacy? Or would they administer regardless of the the condition any of the 150 placebo group still alive- even if on a ventilator for more than 3 days?

    MCS world wide are showing positive effects and I expect (hope) our results to be on pa with the original 12 and the 50 children trial also demonstrates great result - I just don’t think the dream of the Ann the trial gets stopped on efficacy is realistic any more considering some posters a lot smarter than me calculate we are or so close to that 300 mark.

    Id live to be wrong and we get that Ann today




    Last edited by b!ll: 30/07/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.